Dublin, Jan. 24, 2025 (GLOBE NEWSWIRE) -- The "Biosimulation Market Report 2025" has been added to ResearchAndMarkets.com's offering. The biosimulation market size is forecast to see rapid growth in ...
According to MarketsandMarkets™, the Biosimulation Market is projected to grow from about USD 4.27 billion in 2026 to USD ...
The global biosimulation market revenue was around US$ 2.5 billion in 2022 and is estimated to reach US$ 10.6 billion by 2032, growing at a compound annual growth rate (CAGR) of 15.8% during the ...
PRINCETON, N.J., Dec. 21, 2021 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced that the U.S. Food and Drug Administration (FDA) has renewed and ...
PRINCETON, N.J.--(BUSINESS WIRE)--Certara, a global leader in biosimulation, today announced that the U.S. Food and Drug Administration (FDA) has again renewed and expanded its licenses of Certara’s ...
LONDON--(BUSINESS WIRE)--Technavio’s latest market research report on the global biosimulation market predicts the market to witness a CAGR of over 14% during the forecast period. This research report ...
Increase in R&D Investments in the Pharmaceutical and Biotechnology Industries. Growing Adoption of Biosimulation Software By Regulatory Bodies. Growth in the Biologics and Biosimilars Markets. This ...
Biosimulation Market: Detailed Analysis and Premium Industry Insights. This report aims to provide detailed insights into the global biosimulation market. It provides valuable information on the type, ...
Certara, which provides biosimulation software and services used for drug development, filed on Wednesday with the SEC to raise up to $100 million in an initial public offering. However, this is ...
Dublin, Jan. 10, 2018 (GLOBE NEWSWIRE) -- The "Biosimulation Market by Product (Software, Molecular Simulation, In House, Contract Services), Application (Clinical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results